Agnieszka is an intellectual property litigation lawyer and she is responsible for developing local IP practice. She has in-depth expertise and know-how especially in the Life sciences and healthcare sector.
Clients particularly value her ability to bridge the interface between IP rights and regulatory issues. She is commended for organizing and managing intricate national and international patent, trade secret, and trademark disputes in the retail, telecommunications, chemistry, life sciences and healthcare industries.
She supports clients in the negotiation of intellectual property agreements, in the definition of employee invention compensation policies, and in the evaluation of clients’ IP portfolios to strengthen their position in mergers and acquisitions, LBOs, financing transactions, and initial public offerings.
Helping you succeed in tomorrow's world
I am working on intellectual property disputes that often at the cutting-edge of legal developments and that shape the local court practice and life science market. I am experienced in dealing with contemporary and complex legal issues through the courts, intellectual property offices and arbitration. Many intellectual property institutions, such as Polish Patent Office, World Intellectual Proeprty Organizastion or local chambers of advocates or patent and trade mark attorney seeks my expertise in projects that shapes the local IP ecosystem, such as drafting legislation process before the Polish National Ministries.
Agnieszka is a force to be reckoned with; she is a fantastic lawyer with a strong work ethic, and truly knows a lot about the law.
Sztoldman […] is fast emerging as a star of Polish IP practice. One client cites her as “highly knowledgeable and experienced regarding regulatory and trademark law” and praises her for “doing a tremendous job on a highly complex parallel import matter.
Agnieszka Sztoldman is a professional in her field.
Article 73 of the TRIPS agreement provides for the security exceptions that states can invoke todefend their non-compliance with the TRIPS agreement. This is a unique provision in the context ofinternational IP law“ - Russia’s IP threat: what might happen next?